Paper Details
- Home
- Paper Details
The effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice.
Author: NambuAtsushi, SanoHiromi
Original Abstract of the Article :
Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons in the midbrain and shows motor dysfunctions. Zonisamide (ZNS, 1,2-benzisoxazole-3-methanesulfonamide), which was originally developed as an antiepileptic drug, was also found to have beneficial effec...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.neuint.2019.01.011
データ提供:米国国立医学図書館(NLM)
Zonisamide: A Double-Edged Sword in the Treatment of Parkinson's Disease
This study investigates the effects of zonisamide (ZNS), a drug typically used for epilepsy, on L-DOPA-induced dyskinesia (LID), a debilitating movement disorder that can occur in patients with Parkinson’s disease (PD) treated with L-DOPA. While ZNS has been shown to have beneficial effects on motor symptoms in PD, the study reveals that chronic administration of ZNS alongside L-DOPA can paradoxically worsen LID, leading to an increase in the duration and severity of involuntary movements. The researchers explored the underlying neural mechanisms responsible for this effect, analyzing neuronal activity in the substantia nigra pars reticulata (SNr), a key brain region involved in movement control. Their findings suggest that ZNS may alter the balance of activity between the direct and indirect pathways in the basal ganglia, potentially contributing to the worsening of LID.The Complexities of Parkinson’s Disease: A Delicate Balance
This study highlights the intricate interplay of different brain regions and pathways in Parkinson’s disease. It reveals that seemingly beneficial drugs can have unintended consequences, emphasizing the importance of careful monitoring and understanding the potential side effects of medications.Navigating the Labyrinth of Parkinson’s Treatment: A Multi-faceted Approach
Managing Parkinson’s disease requires a comprehensive approach that addresses both motor and non-motor symptoms. This study underscores the need for close monitoring and personalized treatment strategies to optimize outcomes and mitigate potential side effects.Dr. Camel's Conclusion
This research underscores the complexities of treating Parkinson’s disease, a condition that can be as unpredictable as a sandstorm in the desert. It highlights the importance of a cautious and individualized approach to medication, ensuring that benefits outweigh potential risks.Date :
- Date Completed 2019-12-24
- Date Revised 2019-12-24
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.